| Primary |
| Parkinson's Disease |
61.3% |
| Restless Legs Syndrome |
10.0% |
| Hypertension |
6.1% |
| Parkinsonism |
2.8% |
| Depression |
2.4% |
| Product Used For Unknown Indication |
2.2% |
| Insomnia |
2.1% |
| Psychiatric Symptom |
1.6% |
| Constipation |
1.5% |
| Orthostatic Hypotension |
1.3% |
| Osteoporosis |
1.3% |
| Multiple System Atrophy |
1.2% |
| Gastritis |
1.0% |
| Migraine Prophylaxis |
1.0% |
| Anxiety |
0.9% |
| Dyspepsia |
0.7% |
| Atrial Fibrillation |
0.7% |
| Breast Cancer |
0.7% |
| Dyskinesia |
0.7% |
| Migraine |
0.7% |
|
| Pathological Gambling |
12.6% |
| Posture Abnormal |
8.3% |
| Sudden Onset Of Sleep |
7.4% |
| Impulse-control Disorder |
6.5% |
| Somnolence |
6.1% |
| Drug Ineffective |
5.7% |
| Psychotic Disorder |
5.2% |
| Inappropriate Antidiuretic Hormone Secretion |
4.3% |
| Tremor |
4.3% |
| Product Substitution Issue |
3.9% |
| Stereotypy |
3.9% |
| Vomiting |
3.9% |
| Compulsive Shopping |
3.5% |
| Femoral Neck Fracture |
3.5% |
| Ivth Nerve Paresis |
3.5% |
| Panic Attack |
3.5% |
| Restlessness |
3.5% |
| Rhabdomyolysis |
3.5% |
| Suicide Attempt |
3.5% |
| Torticollis |
3.5% |
|
| Secondary |
| Parkinson's Disease |
56.8% |
| Product Used For Unknown Indication |
8.5% |
| Restless Legs Syndrome |
4.9% |
| Insomnia |
3.8% |
| Hypertension |
3.1% |
| Dizziness |
3.0% |
| Parkinsonism |
2.4% |
| Infection Prophylaxis |
2.1% |
| Depression |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Antidepressant Therapy |
1.7% |
| Panic Attack |
1.6% |
| Multiple System Atrophy |
1.2% |
| Schizoaffective Disorder |
1.2% |
| Asthma |
1.0% |
| Constipation |
1.0% |
| Psychiatric Symptom |
1.0% |
| Drug Effect Decreased |
1.0% |
| Anxiety Disorder |
0.9% |
| Pain |
0.9% |
|
| Panic Attack |
23.6% |
| Pathological Gambling |
8.2% |
| Somnolence |
7.1% |
| Vitreous Floaters |
4.9% |
| Hallucination |
4.4% |
| Impulse-control Disorder |
4.4% |
| Inappropriate Antidiuretic Hormone Secretion |
4.4% |
| Coronary Artery Dissection |
3.8% |
| Hallucination, Visual |
3.8% |
| Nausea |
3.8% |
| Posture Abnormal |
3.8% |
| Fall |
3.3% |
| Mental Disorder |
3.3% |
| Restless Legs Syndrome |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Tremor |
3.3% |
| Drug Effect Decreased |
2.7% |
| Obsessive-compulsive Disorder |
2.7% |
| Renal Cyst |
2.7% |
| Restlessness |
2.7% |
|
| Concomitant |
| Parkinson's Disease |
28.5% |
| Drug Use For Unknown Indication |
19.6% |
| Product Used For Unknown Indication |
15.9% |
| Hypertension |
4.4% |
| Restless Legs Syndrome |
4.2% |
| Depression |
3.9% |
| Pain |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Drug Effect Decreased |
2.0% |
| Insomnia |
1.9% |
| Osteoporosis |
1.8% |
| Tremor |
1.6% |
| Multiple Sclerosis |
1.5% |
| Diabetes Mellitus |
1.5% |
| Muscle Spasms |
1.3% |
| Atrial Fibrillation |
1.2% |
| Crohn's Disease |
1.2% |
| Fibromyalgia |
1.2% |
| Anxiety |
1.1% |
| Constipation |
1.1% |
|
| Weight Decreased |
8.5% |
| Tremor |
8.1% |
| Parkinson's Disease |
7.4% |
| Vomiting |
7.0% |
| Pyrexia |
6.3% |
| Somnolence |
5.5% |
| Pain In Extremity |
5.2% |
| Weight Increased |
5.2% |
| Nausea |
4.4% |
| Oedema Peripheral |
4.4% |
| Drug Interaction |
4.1% |
| Pneumonia |
4.1% |
| Shock |
4.1% |
| Urinary Retention |
4.1% |
| Dizziness |
3.7% |
| Drug Ineffective |
3.7% |
| Dyskinesia |
3.7% |
| Neuroleptic Malignant Syndrome |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Death |
3.3% |
|
| Interacting |
| Parkinson's Disease |
85.0% |
| Depression |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Infection |
2.5% |
| Laryngeal Cancer |
2.5% |
| Lipids Abnormal |
2.5% |
| Muscle Spasms |
2.5% |
|
| Incorrect Drug Administration Rate |
40.0% |
| Drug Interaction |
13.3% |
| Paranoia |
13.3% |
| Pathological Gambling |
13.3% |
| Serotonin Syndrome |
6.7% |
| Sudden Onset Of Sleep |
6.7% |
| Transient Psychosis |
6.7% |
|
